Structure and Regulation of The Respiratory Syncytial Virus Polymerase

呼吸道合胞病毒聚合酶的结构和调控

基本信息

  • 批准号:
    10387139
  • 负责人:
  • 金额:
    $ 11.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-20 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT ABSTRACT Non-segmented negative-sense (NNS) RNA viruses include many of our most pathogenic and sometimes deadly viruses, such as measles, rabies, Ebola, and respiratory syncytial virus (RSV). Unfortunately, no effective vaccine or antiviral therapy is available to prevent or treat infection by RSV and many other NNS RNA viruses. Therefore, there is a critical need to define the structural and molecular basis of RNA synthesis of NNS RNA viruses and any differences between them. Our long-term goal is to understand the RNA synthesis machinery of NNS RNA viruses and facilitate the development of antiviral drugs. Our overall objectives in this application are to elucidate the molecular mechanisms of the RSV polymerase and provide functional and structural insights into RSV RNA synthesis. Our underlying hypothesis is that the catalytic activities of RNA polymerization, cap addition, and cap methylation reside within the RSV L protein, and L requires a dynamic assembly with its cofactors P and M2-1 to coordinate these activities during RNA synthesis. The rationale for this project is that understanding the mechanism of the RSV RNA synthesis is likely to offer robust scientific frameworks whereby new strategies to investigate related NNS RNA viruses can be developed. To test the central hypothesis, we will define the functional organization of the RSV L protein and determine the structure of the RSV polymerase using cryo-EM. We will also define the regulatory mechanisms of the RSV transcription by M2-1. These results are expected to have a broader impact beyond RSV because the shared strategies of RNA synthesis machines among NNS RNA viruses imply that our findings will be relevant to all members of this order. This proposed research program is innovative, in the applicant’s opinion, because the proposed research will lay solid foundations for in-depth mechanistic studies of the novel enzymatic activities of NNS RNA viruses and define novel structural and biochemical features of the RSV L protein as well as provide novel insights on the regulation of RSV RNA synthesis. The proposed research is significant because it leverages the power of interdisciplinary approaches that include single-particle cryo-EM to open new horizons for visualizing key stages of RSV RNA synthesis effectively. Ultimately, such knowledge has the potential of offering new opportunities for the rational design of novel antiviral drugs to treat the devastating diseases that RSV and related NNS RNA viruses cause.
项目摘要 非节段负义(NNS)RNA病毒包括许多我们最致病的,有时是致命的 病毒,如麻疹、狂犬病、埃博拉和呼吸道合胞病毒(RSV)。不幸的是,没有有效的 疫苗或抗病毒疗法可用于预防或治疗RSV和许多其它NNS RNA病毒的感染。 因此,迫切需要确定NNS RNA合成的结构和分子基础 病毒和它们之间的任何差异。我们的长期目标是了解RNA合成机制 NNS RNA病毒,并促进抗病毒药物的开发。本申请的总体目标 旨在阐明RSV聚合酶的分子机制,并提供功能和结构方面的见解 RSV RNA的合成。我们的基本假设是,RNA聚合的催化活性, 此外,帽甲基化存在于RSV L蛋白内,并且L需要与其 辅因子P和M2-1在RNA合成过程中协调这些活动。该项目的基本原理是, 了解RSV RNA合成的机制可能会提供强大的科学框架, 可以开发研究相关NNS RNA病毒的新策略。为了验证中心假设,我们将 定义RSV L蛋白的功能组织,并使用 冷冻电镜我们还将确定M2-1对RSV转录的调控机制。这些结果 预计将产生更广泛的影响,超越RSV,因为RNA合成机器的共享策略 在NNS RNA病毒中,这意味着我们的发现将与该目的所有成员相关。这一拟议 在申请人看来,研究计划是创新的,因为拟议的研究将奠定坚实的基础 NNS RNA病毒的新酶活性的深入机制研究的基础,并定义 RSV L蛋白的新的结构和生化特征,以及提供新的见解的调控 RSV RNA的合成。拟议的研究是重要的,因为它利用了跨学科的力量 包括单颗粒冷冻EM在内的方法为RSV RNA关键阶段的可视化开辟了新的视野 合成有效。最终,这些知识有可能为理性人提供新的机会。 设计新的抗病毒药物来治疗RSV和相关NNS RNA病毒引起的毁灭性疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bo Liang其他文献

Bo Liang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bo Liang', 18)}}的其他基金

Structure and Regulation of The Respiratory Syncytial Virus Polymerase
呼吸道合胞病毒聚合酶的结构和调控
  • 批准号:
    10212417
  • 财政年份:
    2019
  • 资助金额:
    $ 11.57万
  • 项目类别:
Structure and Regulation of The Respiratory Syncytial Virus Polymerase
呼吸道合胞病毒聚合酶的结构和调控
  • 批准号:
    10020418
  • 财政年份:
    2019
  • 资助金额:
    $ 11.57万
  • 项目类别:
Structure and Regulation of The Respiratory Syncytial Virus Polymerase
呼吸道合胞病毒聚合酶的结构和调控
  • 批准号:
    10225187
  • 财政年份:
    2019
  • 资助金额:
    $ 11.57万
  • 项目类别:
Structure and Regulation of The Respiratory Syncytial Virus Polymerase
呼吸道合胞病毒聚合酶的结构和调控
  • 批准号:
    10745849
  • 财政年份:
    2019
  • 资助金额:
    $ 11.57万
  • 项目类别:
Structure and Regulation of The Respiratory Syncytial Virus Polymerase
呼吸道合胞病毒聚合酶的结构和调控
  • 批准号:
    10455531
  • 财政年份:
    2019
  • 资助金额:
    $ 11.57万
  • 项目类别:
Structure and Regulation of The Respiratory Syncytial Virus Polymerase
呼吸道合胞病毒聚合酶的结构和调控
  • 批准号:
    10887139
  • 财政年份:
    2019
  • 资助金额:
    $ 11.57万
  • 项目类别:
Structure and Regulation of The Respiratory Syncytial Virus Polymerase
呼吸道合胞病毒聚合酶的结构和调控
  • 批准号:
    10709519
  • 财政年份:
    2019
  • 资助金额:
    $ 11.57万
  • 项目类别:
Structure and Regulation of The Respiratory Syncytial Virus Polymerase
呼吸道合胞病毒聚合酶的结构和调控
  • 批准号:
    10455215
  • 财政年份:
    2019
  • 资助金额:
    $ 11.57万
  • 项目类别:
Novel Extended Release Povidone Iodine Ophthalmic Drop for Viral Conjunctivitis
新型缓释聚维酮碘滴眼液治疗病毒性结膜炎
  • 批准号:
    9519433
  • 财政年份:
    2016
  • 资助金额:
    $ 11.57万
  • 项目类别:

相似海外基金

Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children
用于儿童抗病毒治疗的剂量灵活组合 3D 打印输送系统
  • 批准号:
    10682185
  • 财政年份:
    2023
  • 资助金额:
    $ 11.57万
  • 项目类别:
COVID-19 Immunologic Antiviral therapy with Omalizumab (CIAO trial) - An Adaptive Phase II Randomized-Controlled Clinical Trial
使用奥马珠单抗进行 COVID-19 免疫抗病毒治疗(CIAO 试验)——适应性 II 期随机对照临床试验
  • 批准号:
    475843
  • 财政年份:
    2022
  • 资助金额:
    $ 11.57万
  • 项目类别:
    Studentship Programs
COVID-19 Immunologic Antiviral therapy with Omalizumab (CIAO trial) - An Adaptive Phase II Randomized-Controlled Clinical Trial
使用奥马珠单抗进行 COVID-19 免疫抗病毒治疗(CIAO 试验)——适应性 II 期随机对照临床试验
  • 批准号:
    474485
  • 财政年份:
    2022
  • 资助金额:
    $ 11.57万
  • 项目类别:
    Studentship Programs
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
用于抗病毒治疗的布尼亚病毒核酸内切酶抑制剂的发现
  • 批准号:
    10683329
  • 财政年份:
    2022
  • 资助金额:
    $ 11.57万
  • 项目类别:
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
用于抗病毒治疗的布尼亚病毒核酸内切酶抑制剂的发现
  • 批准号:
    10481430
  • 财政年份:
    2022
  • 资助金额:
    $ 11.57万
  • 项目类别:
An interdisciplinary approach towards antiviral therapy discovery
抗病毒疗法发现的跨学科方法
  • 批准号:
    nhmrc : 1196520
  • 财政年份:
    2021
  • 资助金额:
    $ 11.57万
  • 项目类别:
    Investigator Grants
Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapy
应用“组学”方法预测退伍军人在使用直接作用抗病毒疗法治愈 HCV 后的肝失代偿事件和肝细胞癌
  • 批准号:
    10260234
  • 财政年份:
    2021
  • 资助金额:
    $ 11.57万
  • 项目类别:
Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapy
应用“组学”方法预测退伍军人在使用直接作用抗病毒疗法治愈 HCV 后的肝失代偿事件和肝细胞癌
  • 批准号:
    10548114
  • 财政年份:
    2021
  • 资助金额:
    $ 11.57万
  • 项目类别:
Disparities in the Diffusion of Direct-Acting Antiviral Therapy for Hepatitis C among Baby Boomers: A Mixed-Methods Study
婴儿潮一代丙型肝炎直接作用抗病毒疗法传播的差异:一项混合方法研究
  • 批准号:
    10400318
  • 财政年份:
    2020
  • 资助金额:
    $ 11.57万
  • 项目类别:
COVID-19 Immunologic Antiviral therapy with Omalizumab (CIAO trial)
使用奥马珠单抗进行 COVID-19 免疫抗病毒治疗(CIAO 试验)
  • 批准号:
    449805
  • 财政年份:
    2020
  • 资助金额:
    $ 11.57万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了